NCT03360890 2026-03-13
iPRIME
University of Chicago
Phase 2 Active not recruiting
Clinical Trials
5 trialsNCT07419932 2026-02-19
NeoLATC
Fujian Medical University
Recruiting
NCT05119296 2025-12-22
Phase II Trial of Pembrolizumab in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer
Stanford University
Phase 2 Active not recruiting
NCT07010393 2025-06-08
Genotype-Driven Neoadjuvant Therapy for Locally Advanced Thyroid Cancer: A Real-World Cohort Study
Fujian Medical University
Phase 4 Not yet recruiting
NCT03012620 2024-02-28
AcSé
UNICANCER
Phase 2 Completed